Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Madrigal Pharmaceuticals (MDGL) Other financing activities (2022 - 2023)

Historic Other financing activities for Madrigal Pharmaceuticals (MDGL) over the last 5 years, with Q3 2023 value amounting to $75000.0.

  • Madrigal Pharmaceuticals' Other financing activities changed N/A to $75000.0 in Q3 2023 from the same period last year, while for Jun 2024 it was $75000.0, marking a year-over-year decrease of 7395.83%. This contributed to the annual value of $363000.0 for FY2023, which is 5902.93% down from last year.
  • Latest data reveals that Madrigal Pharmaceuticals reported Other financing activities of $75000.0 as of Q3 2023.
  • In the past 5 years, Madrigal Pharmaceuticals' Other financing activities ranged from a high of $886000.0 in Q2 2022 and a low of $75000.0 during Q2 2023